Clinical and Experimental Hypertension (Apr 2021)

Hsa_circ_0037897 may be a risk factor for essential hypertension via hsa-miR-145-5p

  • Zhenbo Tao,
  • Shuying Zheng,
  • Xin He,
  • Jihan Sun,
  • Canxia He,
  • Lina Zhang

DOI
https://doi.org/10.1080/10641963.2020.1860081
Journal volume & issue
Vol. 43, no. 3
pp. 281 – 286

Abstract

Read online

Objectives: This study aims to investigate the association between hsa_circ_0037897 and essential hypertension (EH) and to evaluate the diagnostic value of biomarker hsa_circ_0037897 in EH. Methods: This study included 92 EH patients and 92 sex- and age- (±3 years) matched subjects as control. qRT-PCR was performed to measure the expression level of circRNA and miRNA. Logistic regression analysis model was used to assess independent association between hsa_circ_0037897 and EH. Results: The expression level of hsa_circ_0037897 in EH patients was significantly higher (p < .001) compared to the control group, while hsa-miR-145-5p had significantly lower expression(p = .002) than the control group. The area under the ROC curve (AUC) of hsa_circ_0037897 was 0.656. Furthermore, the AUC increased to 0.714 when hsa_circ_0037897 was combined with hsa-miR-145-5p, BMI and smoking. Conclusion: The present results suggested that the high expression of hsa_circ_0037897 may be a risk factor for EH, and hsa_circ_0037897 has certain diagnostic value for EH.

Keywords